When was BioTissue founded?

BioTissue was founded in 2001 and raised its 1st funding round 5 years after it was founded.

Where is BioTissue located?

BioTissue is headquartered in Miami, United States. It is registered at Miami, Florida.

How many employees does BioTissue have?

As of Jun 30, 2026, the latest employee count at BioTissue is 372.

Is BioTissue a funded company?

BioTissue is a funded company, having raised a total of $110M across 19 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Sep 15, 2006.

When was the latest funding round of BioTissue?

BioTissue's latest funding was a $***** Grant (prize money) round on Jun 21, 2021, with participation from 1 investor.

Where does BioTissue rank among its competitors?

BioTissue ranks 437th amongst 2719 active competitors, of which 932 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Immuneel, which secured $10.5M in Jun, 2026.

Who are the top competitors of BioTissue?

BioTissue's top competitors include Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences. Among them, Immuneel secured the most recent funding round in June, 2026.

BioTissue - 2026 Company Profile, Team, Funding & Competitors

BioTissue is a series C company based in Miami (United States), founded in 2001 by Amy Tseng. It operates as a Developer of regenerative biologic therapies for eye care. BioTissue has raised $110M in funding from investors like Ballast Point Ventures, RC Capital and EW Healthcare Partners. The company has 2719 active competitors, including 932 funded and 681 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences.

Company Details

Developer of regenerative biologic therapies for eye care. The company offers a range of products that aim to help improve patient outcomes in regenerative wound healing AmnioGraft, Prokera, Neox 1K, and more.

Website: biotissue.com
Social
Phone Number: +1 **********
Registered Address: Miami, Florida

Key Metrics

Founded Year

2001

Location

Miami, United States

Stage

Series C

Total Funding

$110M in 19 rounds

Latest Funding Round

Grant (prize money), Jun 21, 2021, $*****

Investors

Ballast Point Ventures & 3 more

Ranked

437^th among 2719 active competitors

Employee Count

372 as on Jun 30, 2026

Similar Companies

Viridian Therapeutics & 372 more

View BioTissue's full profile

BioTissue is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Tissuetech, Inc. CIN: 20131722241 , United States, Deadpooled	Dec 19, 2013	$5M - $25M (As on Oct 10, 2013)	-	-
TISSUE TECH, INC CIN: 651116071 , United States, Active	Dec 31, 1999	-	311 (As on Dec 31, 2024)	-

BioTissue has raised a total funding of $110M over 19 rounds. Its first funding round was on Sep 15, 2006. Its latest funding round was a Grant (prize money) round on Jun 21, 2021 for $*****. 1 investor participated in its latest round. BioTissue has 4 institutional investors.

Here is the list of recent funding rounds of BioTissue:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 21, 2021	7369083	Grant (prize money)	4566578	9288807	1399579	9306300
Apr 12, 2019	4893429	Series C	2105995	9333298	4604802	Ballast Point Ventures
Nov 18, 2016	3553626	Grant (prize money)	8658653	4445824	8854198	HHS

Access funding benchmarks and valuations. Sign up today!

View details of BioTissue's funding rounds and investors

The founders of BioTissue is Amy Tseng.

Here are the details of BioTissue's key team members:

Amy Tseng: Founder and Board Member of BioTissue.

View details of BioTissue's Founder profiles and Board Members

BioTissue's employee count trend

BioTissue has 372 employees as of Jun 26. Here is BioTissue's employee count trend over the years:

Uncover BioTissue's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of BioTissue include Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences. Here is the list of Top 10 competitors of BioTissue, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jazz Pharmaceuticals 2003, Dublin (Ireland), Public	Developer of novel biopharmaceutical medicines for unmet medical needs	$265M	Versant Ventures, Prospect Venture Partners ... & 14 others	82/100
2nd	Sana Biotechnology 2018, Seattle (United States), Public	Developer of engineered cell therapies for treating various human diseases	$821M	Baillie Gifford, Google Ventures & 17 others	75/100
3rd	Ideaya Biosciences 2015, San Francisco (United States), Public	Developer of oncology-focused precision medicine using molecular diagnostics	$157M	BVF Partners, Boxer Capital & 15 others	72/100
4th	Sutro Biopharma 2003, United States, Public	Developer of antibody-based therapeutics for cancer therapy	$175M	Skyline Ventures, SV Health Investors & 17 others	72/100
5th	Syndax 2005, Waltham (United States), Public	Developer of targeted therapies for the treatment of cancer	$198M	Fidelity Investments, Domain Associates & 19 others	72/100
6th	Karyopharm 2008, Newton (United States), Public	Biopharmaceutical company focused on developing and commercializing innovative cancer therapies	$98.4M	Foresite Capital, Avidity Partners & 16 others	71/100
7th	C4 Therapeutics 2016, Cambridge (United States), Public	Developer of small molecule drugs for treating cancer	$223M	Cobro Ventures, Perceptive Advisors & 27 others	71/100
8th	Immuneel 2018, Bengaluru (India), Series B	Developer of T-cell therapies for the treatment of cancer	$49.8M	True North, Eight Roads Ventures & 23 others	71/100
9th	Zymeworks 2003, Vancouver (Canada), Public	Developer of bi-specific antibodies & antibody-drug conjugates to treat cancer	$146M	CTI Life Sciences Fund, Advanced Biotechnologies Venture Fund ... & 17 others	71/100
10th	Harbour BioMed 2016, Shanghai (China), Public	Developer of antibody therapeutics in immunology and oncology disease	$313M	GIC, Hudson Bay Capital & 19 others	71/100
437th	BioTissue 2001, Miami (United States), Series C	Developer of regenerative biologic therapies for eye care	$110M	Ballast Point Ventures, RC Capital & 2 others	52/100